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Abstract
A 62-year-old male presented with symptoms of urinary obstruction and elevated serum prostate-
specific antigen level of 3.61 ng/mL. Prostate needle biopsies showed benign prostatic tissue with a
focus of crowded glands with minimal cytological atypia, fairly well-circumscribed with infiltrative
appearance of glands at the edges. This focus had both small and larger glands with similar
histological features. This focus was strongly positive for alpha-methylacyl-coenzyme A-racemase
(AMACR), but showed scattered patchy staining with basal cell markers (p63 and CK903/34βE12).
Hence, the final histologic diagnosis was benign prostatic tissue with a focus of florid adenosis. Two
subsequent follow-up prostate needle biopsies performed six and 12 months later both showed
benign prostatic tissue with atrophic changes. This case highlights the utility of these three
immunostains (AMACR, p63 and CK903/34βE12) in the accurate diagnosis of adenosis of the
prostate on needle biopsy, and avoiding its misinterpretation as prostate adenocarcinoma.
Background
Atypical adenomatous hyperplasia (AAH) or adenosis of
the prostate is a pseudoneoplastic lesion that can mimic
prostate adenocarcinoma because of its cytologic and
architectural features [1-3]. For many years, atypical epi-
thelial lesions of the prostate have been known to occur,
but much refining of this knowledge has evolved over the
last two decades. Initially two lesions, prostatic intraepi-
thelial neoplasia (PIN) and AAH, were assumed to be pre-
cursors of prostatic adenocarcinoma [1-3]. However, PIN
now remains as the only well-proven preneoplastic condi-
tion with clinical significance. AAH is no longer consid-
ered a premalignant lesion but rather a benign small
glandular process of the transition zone that simulates aci-
nar adenocarcinoma [1-3]. Since AAH occurs predomi-
nantly in the transition zone, which is only rarely sampled
in needle biopsy, it is uncommon to see examples of this
lesion in biopsy specimens. However, as the sampling of
the transition zone of the prostate has become more fre-
quent recently with ultrasound-guided multiple segmen-
tal prostate biopsies [4] the practicing surgical
pathologists must be aware of the histologic features of
AAH of the prostate in needle biopsy specimens, in order
to avoid misinterpretation of AAH of the prostate, a
benign lesion, as prostate adenocarcinoma. Additionally,
because some patients showing raised prostate specific
antigen levels and negative peripheral zone biopsy may
present with transition zone prostatic adenocarcinoma,
sampling of the transition zone of the prostate by needle
biopsy and the identification of AAH are likely to increase
[4].
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Case presentation
A 62-year-old male was referred to his urologist for symp-
toms of urinary obstruction and an elevated serum pros-
tate-specific antigen (PSA) level of 3.61 ng/mL. Digital
rectal examination and ultrasound revealed an ill-defined
nodule in the prostate suggestive of malignancy. A needle
biopsy was performed.
The histologic section of one needle biopsy was character-
ized at low-power examination by the replacement of nor-
mal prostatic tissue by a proliferation of haphazardly
arranged glands, partially arranged in an ill-defined nod-
ule. The lesions had an infiltrative aspect at their edge, but
the glands were not admixed with normal prostatic acini.
At medium power, the proliferating glands were often slit-
like, variably sized and shaped, alternating small and
rounded acini with elongated and branching ones (Figure
1A &1B). Occasional solid nests and cords could be seen.
The atypical acini were lined by epithelial secretory cells
with clear eosinophilic cytoplasm (Figure 1C). The nuclei
were regular, rounded to oval, and slightly larger than
those of the adjacent normal prostatic acini. There were
inconspicuous nucleoli. There were a few focally promi-
nent basally located cells with dense amphophilic cyto-
plasm. Eosinophilic crystalloids were present within some
acinar lumina (Figure 1C &1D).
Immunohistochemical (IHC) stains revealed strong reac-
tivity for alpha-methylacyl-coenzyme A-racemase
(AMACR) in both small and large glands (Figure 2A &2B),
patchy reactivity for p63 (Figure 2C) and patchy reactivity
for high-molecular-weight cytokeratin CK903/34βE12
(Figure 2D).
The final histologic diagnosis was benign prostatic tissue
with a focus of florid AAH. Two subsequent follow-up
prostate needle biopsies performed six and 12 months
later both showed benign prostatic tissue with atrophic
changes.
Discussion
AAH of the prostate is a microglandular lesion and a rec-
ognized mimicker of small acinar adenocarcinoma [1-3].
AAH is characterized by a proliferation of prostatic glands
with abnormal architectural patterns, but without signifi-
cant cytologic atypia. AAH of the prostate is usually an
incidental finding in transurethral resections or simple
prostatectomies performed in the clinical setting of
benign prostatic hyperplasia. The prevalence of AAH in
Histologic (hematoxylin-eosin) findings of atypical adenoma- tous hyperplasia of the prostate Figure 1
Histologic (hematoxylin-eosin) findings of atypical 
adenomatous hyperplasia of the prostate. (A) 
Crowded haphazardly arranged variably sized glands with 
infiltrative appearance of glands at the edges. Original magni-
fication × 200. (B) Predominantly small glands lined by epithe-
lial secretory cells with clear eosinophilic cytoplasm and 
minimal cytological atypia. Original magnification × 400. (C) 
Predominantly large glands lined by epithelial secretory cells 
with clear eosinophilic cytoplasm and minimal cytological aty-
pia. Original magnification × 400. (D) Predominantly large 
glands lined by epithelial secretory cells with clear eosi-
nophilic cytoplasm, minimal cytological atypia with inconspic-
uous nucleoli, few focally prominent basally located cells with 
dense amphophilic cytoplasm, and luminal eosinophilic crys-
talloids. Original magnification × 600.
Immunohistochemical findings of atypical adenomatous  hyperplasia of the prostate Figure 2
Immunohistochemical findings of atypical adenoma-
tous hyperplasia of the prostate. (A) Strong reactivity 
for alpha-methylacyl-coenzyme A-racemase in predominantly 
small glands. Original magnification × 200. (B) Strong reactiv-
ity for alpha-methylacyl-coenzyme A-racemase in predomi-
nantly large glands. Original magnification × 200. (C) Patchy 
reactivity for p63 in both small and large glands. Original 
magnification × 200. (D) Patchy reactivity for high-molecular-
weight cytokeratin CK903/34βE12 in both small and large 
glands. Original magnification × 200.Diagnostic Pathology 2008, 3:34 http://www.diagnosticpathology.org/content/3/1/34
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transurethral prostatectomy specimens without cancer
ranges from 1.6% to 7.3% [5] compared to its prevalence
of 0.8% in needle biopsy specimens [6]. Their rarity in
needle biopsies of the prostate is attributable to the fact
that sampling of the transition zone is not common in
needle biopsies. Although, AAH can be diagnosed
throughout the prostate, it is most often located in the
transition zone of the prostate in intimate association
with benign nodular hyperplasia [7]. Since the frequency
of needle biopsies, including tissue from the transition
zone, is likely to increase due to the introduction of ultra-
sound-guided multiple segmental prostate biopsy [4],
knowledge of the main diagnostic histologic features of
AAH would represent an important issue in genitourinary
surgical pathology. The diagnosis of AAH in needle biop-
sies, as seen in the case herein presented, relies on both
histologic features in hematoxylin and eosin-stained
slides and immunohistochemical features.
Microscopically, AAH is a localized proliferative lesion
consisting of small amounts of atypical epithelial cells
arranged in irregular glandular patterns, often within or
adjacent to typical hyperplastic nodules [8]. At low mag-
nification, it is usually partially circumscribed with a
pushing rather than infiltrating border, although the
small acini may show a limited degree of infiltrative fea-
tures at the margins. The individual glands are closely
packed but separate and show no evidence of fusion. The
glands show some variation in size and shape and are
lined by cuboidal to low columnar cells with moderate to
abundant clear or lightly eosinophilic cytoplasm [6,9].
The basal cells are usually recognized at least focally. The
luminal borders are often irregular and somewhat serrated
in contrast to the rigid borders that typify small acinar car-
cinoma. The lumens are often empty but may contain cor-
pora amylacea and in some instances luminal
eosinophilic crystalloids [5,9]. The nuclei are round to
oval, slightly enlarged, and with uniform fine chromatin
and inconspicuous or small nucleoli [9]. AAH can be dif-
ficult to distinguish from low-grade prostatic adenocarci-
noma (Gleason pattern 1 or 2) because both are located
in the transition zone and show small acinar proliferation
and intraluminal crystalloids [9]. The two distinguishing
features of AAH are the lack of significant cytological aty-
pia and the presence of patchy basal cells, which can be
demonstrated by patchy immunostaining for high molec-
ular-weight cytokeratin (CK903/34βE12) or p63 [7-9]. In
contrast, prostatic adenocarcinoma usually shows notable
nuclear atypia, lacks basal cells, and rarely expresses high
molecular weight cytokeratin [10]. Yang and colleagues
[11] found that AMACR was focally expressed in 10% of
cases and diffusely positive in only 7.5% of cases of AAH.
The biological significance of AMACR expression in a
small subset of AAH remains to be determined. AAH dif-
fers from sclerosing adenosis, another benign mimicker of
prostate adenocarcinoma, since sclerosing adenosis dis-
plays myoepithelial features of the basal cells and an exu-
berant stroma of fibroblasts and loose ground substance
[12].
While circumstantial evidence exists, there is lack of proof
of a relationship between AAH and adenocarcinoma. It
has been suggested that AAH is a precursor of some low-
grade transition zone carcinomas but the lack of an
increased prevalence of AAH in prostate glands with tran-
sition zone carcinoma argues against this hypothesis.
Clearly, there is less evidence linking AAH to carcinoma
than there is for high-grade PIN and cancer. Therefore, the
major importance of AAH is its potential for being misdi-
agnosed as adenocarcinoma. Biochemical and molecular
analyses of AAH have generated inconclusive results.
There is limited data that AAH has a proliferation rate
higher than hyperplasia but lower than adenocarcinoma
[1,7,8,13]. By the use of fluorescent in situ hybridization
analysis, chromosomal anomalies were seen in only 9%
of AAH cases, compared with 55% of prostatic adenocar-
cinoma cases [13]. Two independent studies showed that
AAH contains genetic alterations commonly found in
early prostatic carcinoma, with changes being reported in
47% or 12% of AAH cases, respectively [8,14]. Recent
cytogenetic analyses have detected abnormalities of chro-
mosome 8 in a very small proportion (4–7%) of AAH
cases [7,8]. The recent finding of molecular alterations in
AAH including immunoreactivity for AMACR, a marker
linked to prostate adenocarcinoma, suggests that at least a
subset of AAH cases might be related to prostate carci-
noma of the transition zone [11,13,14].
The widespread use of PSA screening has led to an increase
in prostate needle biopsies and, subsequently, an increase
in earlier detection of prostate carcinoma. This trend has
also led to an increase in the number of equivocal diag-
noses on prostate biopsy specimens. Surgical pathologists
must make critical decisions on an increasing number of
prostate needle biopsy specimens with only small foci of
atypical glands. In this setting, the mimics of prostate can-
cer must be distinguished from a small focus of adenocar-
cinoma. The distinction of benign small acinar
proliferations (benign mimickers of cancer) from atypical
acinar proliferations suspicious for cancer is crucial, since
the subsequent clinical approach is different. Biopsies har-
boring a small focus of atypical glands frequently repre-
sent an under-sampled cancer and a subsequent biopsy
will show cancer in up to 50% of cases [15]. In contrast,
following a diagnosis of benign mimickers of cancer (such
as atrophy or AAH), a re-biopsy is usually not indicated.
Conclusion
AAH is a transition zone lesion of the prostate that can
simulate small acinar carcinoma. By itself positive immu-Publish with BioMed Central    and   every 
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nostaining for AMACR is not diagnostic for carcinoma
because the latter is also positive in high-grade PIN and
some benign mimickers of adenocarcinoma. The case
herein presented highlights the utility of AMACR, p63 and
CK903/34βE12 immunostaining in the accurate diagno-
sis of adenosis of the prostate, a benign mimicker of pros-
tate adenocarcinoma.
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